Latest La Jolla Institute for Allergy and Immunology Stories
This Year Marks the 20th Anniversary of LLS's Prestigious Translational Research Program WHITE PLAINS, N.Y., Oct.
ANN ARBOR, Mich., Aug.
In experiments with mice, Johns Hopkins Kimmel Cancer Center scientists have identified an enzyme involved in the regulation of immune system T cells that could be a useful target in treating asthma and boosting the effects of certain cancer therapies.
A major study from researchers at the La Jolla Institute for Allergy and Immunology provides new revelations about the intricate pathways involved in turning on T cells, the body's most important disease-fighting cells, and was published today in the prestigious scientific journal Nature.
A virus most people probably have never heard of, but that the majority of us carry, is the No. 1 infectious cause of congenital birth defects in the U.S. today.
Most people probably know that heart disease remains the nation's No. 1 killer.
Researchers at the La Jolla Institute for Allergy & Immunology have proven – for the first time in human tissues -- the specific immune system T cells which trigger the destruction of type 1 diabetes in the pancreas.
A war is being waged in the pancreases of millions of people throughout the world.
Most of the time, the immune system is the body's protector, warding off invading viruses and bacteria before they can lead to infection and disease.
A La Jolla Institute team, led by leading type 1 diabetes researcher Matthias von Herrath, M.D., has demonstrated the effectiveness of a recently developed computer model in predicting key information about nasal insulin treatment regimens in type 1 (juvenile) diabetes.
- A transitional zone between two communities containing the characteristic species of each.